 Drug Regimen Compliance: Issues in Clinical Trials and Patient Management
ISBN: 978-0-471-97122-1
Hardcover
212 pages
March 1999
US $230.00
 Add to Cart
This price is valid for United States. Change location to view local pricing and availability. This is a Print-on-Demand title. It will be printed specifically to fill your order. Please allow an additional 1-2 days delivery time for paperbacks, and 3-5 days for hardcovers. The book is not returnable.
|
An online version of this product is available through our subscription-based content service. Visit Wiley InterScience now |
Drug Regimen Compliance Issues in Clinical Trials and Patient Management Edited by Jean-Michel Métry Aardex Ltd., Zug, Switzerland and Urs A. Meyer University of Basel, Switzerland A patient's non-compliance with drug regimens can render drugs ineffective. This not only causes problems for the patient but also large costs for health services. Despite a renewed interest in the subject over the past few years, there is still a dearth of new ideas and perspectives. This volume is written in response to this lack, and seeks to:
* Address key topics, such as regulatory issues and the role of compliance in clinical care
* Provide pointers for trials
* Provide guidelines for the management of patients
* Explore means by which compliance can be monitored
* Suggest the best ways to monitor patient management
Drug Regimen Compliance: Issues in Clinical Trials and Patient Management provides the basis for future steps in improving patient compliance and will be invaluable to pharmacologists, toxicologists, pharmaco-epidemiologists, clinical trial scientists, medical economists and all those prescribing drug regimens.
* Address key topics, such as regulatory issues and the role of compliance in clinical care
* Provide pointers for trials
* Provide guidelines for the management of patients
* Explore means by which compliance can be monitored
* Suggest the best ways to monitor patient management
Drug Regimen Compliance: Issues in Clinical Trials and Patient Management provides the basis for future steps in improving patient compliance and will be invaluable to pharmacologists, toxicologists, pharmaco-epidemiologists, clinical trial scientists, medical economists and all those prescribing drug regimens.
;){kind=link}